Sponsor Pipeline

Pulmovant, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07333183 A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD Pulmonary Hypertension Recruiting
NCT06635850 A Study of Mosliciguat in PH-ILD Pulmonary Hypertension Active, Not Recruiting
Disease Areas
Heart Disease (2) Hypertension (2)
Get alerts when Pulmovant, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free